Pediatric morphea state-of-the-art literature review: Reframing morphea as a systemic disease. Pediatr Dermatol 2021 Sep;38(5):1020-1031
Date
07/18/2021Pubmed ID
34272748DOI
10.1111/pde.14688Scopus ID
2-s2.0-85110352628 1 CitationAbstract
Pediatric morphea is an inflammatory, fibrosing dermatologic disorder. Although morphea may be localized to the skin and subcutaneous tissues, differentiating it from systemic sclerosis, there is increasing evidence that morphea is a manifestation of a systemic inflammatory process, with the potential to involve many organ systems. Given the potential risk for irreversible sequelae, pediatric morphea should be treated early and aggressively. Long-term disease monitoring is essential.
Author List
Sink JR, Chiu YEAuthor
Yvonne E. Chiu MD Vice Chair, Professor in the Dermatology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
ChildDisease Progression
Humans
Scleroderma, Localized
Scleroderma, Systemic
Skin
